Lines of Operation
Teva Lines of Operation Operations

Operations

Teva's Operational Expertise

Teva continues to leverage the size and diversity of its operations to bring the best quality pharmaceutical products to your doorstep

Teva's operational expertise is one of its core competitive advantages. Operational efficiency has become a necessity in the pharmaceutical industry in general, and in generic medicine in particular, due to increasing
competition.

Teva’s vast operational network successfully maintains high standards of performance, efficiency and cost effectiveness. These achievements rely on the company’s unique qualities, among them: 

  • Expert knowledge of pharmaceutical production technologies
  • Presence in all leading markets worldwide
  • In-depth understanding of regulatory requirements and efficient Quality Management System
  • Production-focused new product development
  • Ongoing interaction among Teva's personnel worldwide allows for dissemination of knowledge and ideas

Quick Operational Facts

  • Teva operates in 60 countries
  • Teva distributes products to over 120 markets
  • During 2012, Teva's plants manufactured approximately 73 billion tablets and capsules and over 720 million sterile units
  • Our network consists of 53 manufactoring sites: 41-Solids, 17-Sterile, 14-LCO & 2-Inhalers

The Operational Process

Operational considerations are addressed early in the process of drug development. The operational process typically consists of 3 components:

Procurement

Three main issues are considered at this stage:
  • The availability of  API: either produced in-house or acquired from an external vendor
  • The availability of exipients (inactive ingredients)- which to use and where to purchase 
  • The need for primary and secondary packaging, designed and selected according to the product's characteristics, dosage form and marketing demands

All of Teva's external vendors must comply with our vendor qualification program and are certified by the relevant regulator, as needed.

Production

Teva's Technical Scientific Affairs (TSA) team is responsible for the smooth transfer from the development stage to the production stage.

Types of production facilities correspond to the following product categories:
  • Oral Solids
  • Semi Solids
  • Liquids
  • Sterile
  • Inhalers
  • Biotechnology
Each production facility abides by specific regulatory standards, corresponding to specific market requirements and regulatory demands.

 
The Production Process
The manufacturing process of both generic and innovative drugs is strictly regulated and follows the same, strict, cGMP cGMP tandards both in the lab and on the production site. The production process is generally divided into 5 main stages:
  • Receipt of API, excipients, ingredients, raw materials and packaging materials
  • Manufacturing
  • QA testing
  • Packaging and storage
  • Release and shipping

Shipping and Distribution

Once manufacturing and packaging are completed, products are shipped to our customers. While committed to pre-determined delivery schedules, Teva consistently maintains the integrity and quality of all of its products.

To ensure product quality, drug stability is tested. Findings help determine the required methods of packaging, storage, shipping conditions (e.g.:  frozen/refrigerated) and shelf-life.

Today, special technologies allow for the monitoring of shipping conditions by land, sea or air. Special containers equipped with state of the art devices are utilized, as required.

Our commitment to service quality, coupled with our size and efficiency, enables us to continuously supply our customers, even at times of extreme peaks in demand. Teva continues to leverage the size and diversity of its operations to bring the best quality pharmaceutical products to your doorstep.
M_02